Corelattions Between CD31, CD68, MMP-2 and MMP-9 Expression in Allograft Cardiac Rejection – Immunohistochemical Study
By:
References
- 1. Mangiola M, Marrari M, Feingold B, Zeevi A. Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes. Frontiers in Immunology. 2017;8(4).
- 2. Freystaetter K, Andreas M, Bilban M, Perkmann T, Kaider A, Masetti M, et al. The recipient’s heme oxygenase-1 promoter region polymorphism is associated with cardiac allograft vasculopathy. Transpl Int. 2017;30(5):510-8.
- 3. Nakamura K, Inami M, Morio H, Okuma K, Ito M, Noto T, et al. AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. European Journal of Pharmacology. 2017;796:69-75.
- 4. Colvin Monica M, Cook Jennifer L, Chang P, Francis G, Hsu Daphne T, Kiernan Michael S, et al. Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management. Circulation. 2015;131(18):1608-39.
- 5. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. Journal of the American College of Cardiology. 2004;44(8):1609-18.
- 6. Aharinejad S, Krenn K, Zuckermann A, Schäfer R, Gmeiner M, Thomas A, et al. Serum Matrix Metalloprotease-1 and Vascular Endothelial Growth Factor–A Predict Cardiac Allograft Rejection. American Journal of Transplantation. 2009;9(1):149-59.
- 7. Calé R, Almeida M, Gonçalves P, Rebocho MJ, Raposo L, Teles R, et al. Complicações da biópsia endomiocárdica após transplante cardíaco. Um mal menor. Revista Portuguesa de Cardiologia. 2012;31(2):159-62.
- 8. Michel RP, Berry GJ. Pathology of Transplantation: A Practical Diagnostic Approach: Springer International Publishing; 2016.
- 9. Buszko M, Cardini B, Oberhuber R, Oberhuber L, Jakic B, Beierfuß A, et al. Differential depletion of total T cells and regulatory T cells and prolonged allotransplant survival in CD3Ɛ humanized mice treated with polyclonal anti human thymocyte globulin. PLOS ONE. 2017;12:e0173088.
- 10. Deng MC. The AlloMap™ genomic biomarker story: 10 years after. Clinical Transplantation. 2017;31(3):e12900.
- 11. Yerly P RS, Nobile A, Aubert V, Tozzi PG, Yarol N, Vogt P, Hullin R & Pascual M. Time-Dependent Specificity of Immunopathologic (C4d-CD68) and Histologic Criteria of Antibody-Mediated Rejection for Donor-Specific Antibodies and Allograft Dysfunction in Heart Transplantation. Transplantation. 2015;99(3):586-93.
- 12. Li L, Duan X, Wang H, Wang Q, Lu Y, Yan C, et al. Acute cellular rejection and antibody-mediated rejection in endomyocardial biopsy after heart transplantation: A retrospective study from a single medical center. International Journal of Clinical and Experimental Pathology. 2017;10:4772-9.
- 13. Bayliss J BM, Leet A, Stein AN, Thomson NM & McLean CA.. Late onset antibody mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation. 2008;86(7): 991-7.
- 14. Cheung K, Ma L, Wang G, Coe D, Ferro R, Falasca M, et al. CD31 signals confer immune privilege to the vascular endothelium. Proceedings of the National Academy of Sciences. 2015;112(43):E5815..
- 15. Di Francesco A, Fedrigo M, Santovito D, Natarelli L, Castellani C, De Pascale F, et al. MicroRNA signatures in cardiac biopsies and detection of allograft rejection. The Journal of Heart and Lung Transplantation. 2018;37(11):1329-40.
- 16. Suzuki J-i, Isobe M, Kawauchi M, Endoh M, Amano J, Takamoto S. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of nonhuman primates. Transpl Int. 2000;13(2):106-13.
- 17. Campbell LG, Ramachandran S, Liu W, Shipley JM, Itohara S, Rogers JG, et al. Different Roles for Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in the Pathogenesis of Cardiac Allograft Rejection. American Journal of Transplantation. 2005;5(3):517-28.
- 18. Vanhoutte D, van Almen GC, Van Aelst LN, Van Cleemput J, Droogne W, Jin Y, et al. Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection. Eur Heart J. 2013 Jul;34(25):1930-41.
Language: English
Page range: 172 - 178
Published on: Mar 3, 2020
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Grecu Vasile Bogdan, Onofrei Pavel, Dimitriu Daniela Cristina, Temelie Olinici Doinita, Stoica Laura, Botez Ana Emanuela, Indrei Lucian Laurentiu, Popa Alina Alexandra, Solcan Carmen, Sin Anca Ileana, Cotrutz Elena Carmen, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.